Janssen SWJ - Search Results

1

Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective.

Rigter T, Jansen ME, de Groot JM, Janssen SWJ, Rodenburg W, Cornel MC. Rigter T, et al. Among authors: janssen swj. Front Genet. 2020 Jan 31;11:10. doi: 10.3389/fgene.2020.00010. eCollection 2020. Front Genet. 2020. PMID: 32076434 Free PMC article.

2

Analyzing the contributions of a government-commissioned research project: a case study.

Hegger I, Janssen SW, Keijsers JF, Schuit AJ, van Oers HA. Hegger I, et al. Health Res Policy Syst. 2014 Feb 5;12:8. doi: 10.1186/1478-4505-12-8. Health Res Policy Syst. 2014. PMID: 24498894 Free PMC article.

3

Enhancing the contribution of research to health care policy-making: a case study of the Dutch Health Care Performance Report.

Hegger I, Marks LK, Janssen SW, Schuit AJ, van Oers HA. Hegger I, et al. J Health Serv Res Policy. 2016 Jan;21(1):29-35. doi: 10.1177/1355819615599565. Epub 2015 Aug 16. J Health Serv Res Policy. 2016. PMID: 26282364

4

Contributions of knowledge products to health policy: a case study on the Public Health Status and Forecasts Report 2010.

Hegger I, Kok MO, Janssen SW, Schuit AJ, van Oers HA. Hegger I, et al. Eur J Public Health. 2016 Dec;26(6):922-927. doi: 10.1093/eurpub/ckw097. Epub 2016 Jul 24. Eur J Public Health. 2016. PMID: 27452890 Free PMC article.

5

Research for Policy (R4P): development of a reflection tool for researchers to improve knowledge utilization.

Hegger I, Marks LK, Janssen SW, Schuit AJ, Keijsers JF, van Oers HA. Hegger I, et al. Implement Sci. 2016 Sep 30;11(1):133. doi: 10.1186/s13012-016-0496-1. Implement Sci. 2016. PMID: 27716245 Free PMC article.

6

Primary endpoint discrepancies were found in one in ten clinical drug trials. Results of an inception cohort study.

van den Bogert CA, Souverein PC, Brekelmans CTM, Janssen SWJ, Koëter GH, Leufkens HGM, Bouter LM. van den Bogert CA, et al. Among authors: janssen swj. J Clin Epidemiol. 2017 Sep;89:199-208. doi: 10.1016/j.jclinepi.2017.05.012. Epub 2017 May 20. J Clin Epidemiol. 2017. PMID: 28535887

7

Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands.

van den Bogert CA, Souverein PC, Brekelmans CTM, Janssen SWJ, Koëter GH, Leufkens HGM, Bouter LM. van den Bogert CA, et al. Among authors: janssen swj. J Clin Epidemiol. 2017 Aug;88:140-147. doi: 10.1016/j.jclinepi.2017.05.001. Epub 2017 May 6. J Clin Epidemiol. 2017. PMID: 28487159

8

Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug Trials.

van den Bogert CA, Souverein PC, Brekelmans CT, Janssen SW, Koëter GH, Leufkens HG, Bouter LM. van den Bogert CA, et al. PLoS One. 2016 Dec 14;11(12):e0167709. doi: 10.1371/journal.pone.0167709. eCollection 2016. PLoS One. 2016. PMID: 27973571 Free PMC article.

9

Occurrence and determinants of selective reporting of clinical drug trials: design of an inception cohort study.

van den Bogert CA, Souverein PC, Brekelmans CT, Janssen SW, van Hunnik M, Koëter GH, Leufkens HG, Bouter LM. van den Bogert CA, et al. BMJ Open. 2015 Jul 7;5(7):e007827. doi: 10.1136/bmjopen-2015-007827. BMJ Open. 2015. PMID: 26152325 Free PMC article.

10

[Non-publication is common among phase 1, single-center, not prospectively registered, or early terminated clinical drug trials].

van den Bogert CA, Souverein PC, Brekelmans CTM, Janssen SWJ, Koëter GH, Leufkens HGM, Bouter LM. van den Bogert CA, et al. Among authors: janssen swj. Ned Tijdschr Geneeskd. 2017;161:D1498. Ned Tijdschr Geneeskd. 2017. PMID: 28659210 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page